Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome

OBJECTIVE: Immunomodulatory drugs and proteasome inhibitors are therapeutic options for polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. This study aimed to evaluate the efficacy and safety of the combination of ixazomib, lenalidomide, and dexam...

Descripción completa

Detalles Bibliográficos
Autores principales: Suichi, Tomoki, Misawa, Sonoko, Sekiguchi, Yukari, Shibuya, Kazumoto, Nakamura, Keigo, Kano, Hiroki, Aotsuka, Yuya, Otani, Ryo, Morooka, Marie, Tsukamoto, Shokichi, Takeda, Yusuke, Mimura, Naoya, Ohwada, Chikako, Sakaida, Emiko, Kuwabara, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492490/
https://www.ncbi.nlm.nih.gov/pubmed/36047093
http://dx.doi.org/10.2169/internalmedicine.8786-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492490/
https://www.ncbi.nlm.nih.gov/pubmed/36047093
http://dx.doi.org/10.2169/internalmedicine.8786-21

Ejemplares similares